This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Boeing: Analysts' Upgrades, Downgrades

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Boeing (BA - Get Report) upgraded at Jesup & Lamont from Hold to Buy. $63 price target. Stock is trading at an attractive risk/reward ratio.

Boeing (BA - Get Report) upgraded at Barclays to Overweight from Equal Weight. Price target jumped to $65 from $57. 2009 and 2010 EPS estimates lowered to $1.20 and $4.40, respectively.

Beckman Coulter (BEC) upgraded at JP Morgan. Rating raised to Overweight from Neutral. Maintains $75 price target and 2009 EPS estimates of $3.82.

Boston Scientific (BSX - Get Report) downgraded at Baird from Outperform to Neutral. $10 price target. Company is reliant on slow-growth markets.

Bucyrus (BUCY) target, estimate raised at Barclays. BUCY price target surged to $73 from $64. 2010 EPS estimate increased to $3.55 from $2.90. Maintain Overweight rating.

Bucyrus (BUCY) rated new Outperform at Morgan Stanley. $71 price target. Terex purchase was a positive and should materially add to earnings.

Chesapeake Energy (CHK) downgraded at Goldman from Buy to Neutral. Valuation call, despite the company's attractive resource upside.

Con-way (CNW) upgraded at BofA/Merrill to Buy from Neutral. Price target set at $45. YRC's market share losses makes valuation increasingly attractive for CNW.

Calpine (CPN) upgraded at Jefferies from Underperform to Hold. $11.50 price target. Company has reduced exposure to gas and trades at an attractive valuation.

Dynegy (DYN) upgraded at Jefferies from Underperform to Hold. Valuation call, based on a $1.80 price target.

Brinker (EAT) downgraded at UBS from Buy to Neutral. $16 price target. Estimates also lowered, as sales trends appear to have deteriorated.

1 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
BA $140.52 -1.27%
BSX $18.27 0.00%
C $54.08 -0.86%
NIHD $0.10 -4.76%
MS $38.20 -1.37%

Markets

DOW 18,010.68 -115.44 -0.64%
S&P 500 2,107.39 -13.40 -0.63%
NASDAQ 5,070.0260 -27.95 -0.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs